MedPath

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private, Subsidiary
Established
1891-01-01
Employees
10K
Market Cap
-
Website
http://www.medschool.wustl.edu

Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity

Not Applicable
Completed
Conditions
Colorectal Cancer
Gynecologic Cancer
Lung Cancer
Interventions
Behavioral: I Can PIC
Other: Historical control survey
Other: Post-intervention survey (I Can PIC participants)
Other: Follow-Up survey (I Can PIC participants)
First Posted Date
2020-03-19
Last Posted Date
2023-05-09
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
150
Registration Number
NCT04314284
Locations
πŸ‡ΊπŸ‡Έ

Washington University School of Medicine, Saint Louis, Missouri, United States

Interventions to Help More Low-income Smokers Quit

Not Applicable
Completed
Conditions
Smoking Behaviors
Tobacco Use Cessation
Health Disparity
Interventions
Behavioral: Tobacco Quitline
Behavioral: Smoke Free Home
First Posted Date
2020-03-17
Last Posted Date
2024-10-10
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
1973
Registration Number
NCT04311983
Locations
πŸ‡ΊπŸ‡Έ

Washington University School of Medicine, Saint Louis, Missouri, United States

In-Home Sensor Monitoring of Older Adults With Cancer

Not Applicable
Withdrawn
Conditions
Cancer
Interventions
Other: In-home sensor monitoring
First Posted Date
2020-03-13
Last Posted Date
2020-09-16
Lead Sponsor
Washington University School of Medicine
Registration Number
NCT04306783

The Role of Oxytocin in the Second Stage of Labor

Not Applicable
Recruiting
Conditions
Labor Complication
Interventions
Other: Discontinue Oxytocin
Drug: Continue Oxytocin
First Posted Date
2020-03-11
Last Posted Date
2024-03-15
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
400
Registration Number
NCT04303702
Locations
πŸ‡ΊπŸ‡Έ

Barnes Jewish Hospital, Saint Louis, Missouri, United States

Intraarticular Antibiotic in TKA

Phase 4
Completed
Conditions
Antibotics in Cementless Knees
Interventions
Drug: Tobramycin Powder
Device: Vancomyscin
First Posted Date
2020-03-05
Last Posted Date
2021-10-05
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
20
Registration Number
NCT04297631
Locations
πŸ‡ΊπŸ‡Έ

Washington University School of Medicine, Saint Louis, Missouri, United States

Potassium Flux in Hemodialysis Patients

Completed
Conditions
Hemodialysis
First Posted Date
2020-02-27
Last Posted Date
2021-01-06
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
25
Registration Number
NCT04287010
Locations
πŸ‡ΊπŸ‡Έ

Washington Univeristy in St Louis, Saint Louis, Missouri, United States

Gated and Non-Gated Dynamic PET/CT Imaging

Not Applicable
Terminated
Conditions
Dynamic PET/CT Imaging
Interventions
Device: Dynamic PET/CT Imaging
First Posted Date
2020-02-25
Last Posted Date
2024-05-20
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
80
Registration Number
NCT04283552
Locations
πŸ‡ΊπŸ‡Έ

Washington University School of Medicine, Saint Louis, Missouri, United States

Feasibility of an Automated Bidet Intervention to Decrease Caregiver Burden

Not Applicable
Completed
Conditions
Caregiver Burnout
Interventions
Behavioral: Automated Bidet
Other: No Intervention
First Posted Date
2020-02-25
Last Posted Date
2024-11-20
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
10
Registration Number
NCT04283123

Diabetes/ Endocrine Surveillance in SDS

Terminated
Conditions
Shwachman-Diamond Syndrome
Interventions
Diagnostic Test: Oral Glucose Tolerance Test
Other: Modified Oral Glucose Tolerance Test
Other: Modified Mixed Meal Tolerance Test
Other: Food Diary
Other: Medical History Questionnaires
Device: Continuous Glucose Monitor
First Posted Date
2020-02-19
Last Posted Date
2024-08-19
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
11
Registration Number
NCT04275479
Locations
πŸ‡ΊπŸ‡Έ

Washington University, Saint Louis, Missouri, United States

Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

Phase 2
Withdrawn
Conditions
Cancer
Interventions
Device: FDG PET/CT
Device: FLT PET/CT
Device: PET/MR
Drug: [F-18] flurothymidine
First Posted Date
2020-02-17
Last Posted Date
2025-01-07
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
30
Registration Number
NCT04271436
Locations
πŸ‡ΊπŸ‡Έ

Washington University School of Medicine, Saint Louis, Missouri, United States

Β© Copyright 2025. All Rights Reserved by MedPath